CRISPR Therapeutics AG (CRSP)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$49.71

Buy

$50.48

arrow-up$1.35 (+2.78%)

Prices updated at 22 May 2026, 00:55 EDT

Prices minimum 15 mins delay

Prices in USD

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.

NASDAQ

0.09%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$50.05 - $47.34
	$78.48 - $35.38
	-
	4,682.59m
	-
	-
	1,447,182
	2.58
	2,409,611.02
	2.85
	96.01m
	CH0334081137
	-6.17
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.